Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab vs Fumaric Acid Esters in Psoriasis
NCT01088165Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Start
- May 2010
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in plaque psoriasis, sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01088165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088165.